LBTSF
Price
$13.36
Change
+$4.35 (+48.28%)
Updated
Jun 26 closing price
Capitalization
2.74B
MKGAF
Price
$129.15
Change
+$1.90 (+1.49%)
Updated
Sep 5 closing price
Capitalization
55.52B
Interact to see
Advertisement

LBTSF vs MKGAF

Header iconLBTSF vs MKGAF Comparison
Open Charts LBTSF vs MKGAFBanner chart's image
Almirall SA
Price$13.36
Change+$4.35 (+48.28%)
Volume$332
Capitalization2.74B
Merck KGaA
Price$129.15
Change+$1.90 (+1.49%)
Volume$594
Capitalization55.52B
LBTSF vs MKGAF Comparison Chart in %
Loading...
MKGAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LBTSF vs. MKGAF commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LBTSF is a Hold and MKGAF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (LBTSF: $13.36 vs. MKGAF: $129.15)
Brand notoriety: LBTSF and MKGAF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: LBTSF: 100% vs. MKGAF: 74%
Market capitalization -- LBTSF: $2.74B vs. MKGAF: $55.52B
LBTSF [@Pharmaceuticals: Generic] is valued at $2.74B. MKGAF’s [@Pharmaceuticals: Generic] market capitalization is $55.52B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LBTSF’s FA Score shows that 1 FA rating(s) are green whileMKGAF’s FA Score has 1 green FA rating(s).

  • LBTSF’s FA Score: 1 green, 4 red.
  • MKGAF’s FA Score: 1 green, 4 red.
According to our system of comparison, LBTSF is a better buy in the long-term than MKGAF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MKGAF’s TA Score shows that 3 TA indicator(s) are bullish.

  • MKGAF’s TA Score: 3 bullish, 4 bearish.

Price Growth

LBTSF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while MKGAF (@Pharmaceuticals: Generic) price change was +4.36% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.08%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +86.48%.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MKGAF($55.5B) has a higher market cap than LBTSF($2.74B). LBTSF has higher P/E ratio than MKGAF: LBTSF (115.63) vs MKGAF (16.81). LBTSF YTD gains are higher at: 45.645 vs. MKGAF (-14.786). MKGAF has higher annual earnings (EBITDA): 5.87B vs. LBTSF (195M). MKGAF has more cash in the bank: 1.57B vs. LBTSF (323M). LBTSF has less debt than MKGAF: LBTSF (405M) vs MKGAF (9.4B). MKGAF has higher revenues than LBTSF: MKGAF (21.2B) vs LBTSF (1.05B).
LBTSFMKGAFLBTSF / MKGAF
Capitalization2.74B55.5B5%
EBITDA195M5.87B3%
Gain YTD45.645-14.786-309%
P/E Ratio115.6316.81688%
Revenue1.05B21.2B5%
Total Cash323M1.57B21%
Total Debt405M9.4B4%
FUNDAMENTALS RATINGS
LBTSF vs MKGAF: Fundamental Ratings
LBTSF
MKGAF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
23
Undervalued
PROFIT vs RISK RATING
1..100
75100
SMR RATING
1..100
9170
PRICE GROWTH RATING
1..100
4062
P/E GROWTH RATING
1..100
8792
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MKGAF's Valuation (23) in the null industry is in the same range as LBTSF (32). This means that MKGAF’s stock grew similarly to LBTSF’s over the last 12 months.

LBTSF's Profit vs Risk Rating (75) in the null industry is in the same range as MKGAF (100). This means that LBTSF’s stock grew similarly to MKGAF’s over the last 12 months.

MKGAF's SMR Rating (70) in the null industry is in the same range as LBTSF (91). This means that MKGAF’s stock grew similarly to LBTSF’s over the last 12 months.

LBTSF's Price Growth Rating (40) in the null industry is in the same range as MKGAF (62). This means that LBTSF’s stock grew similarly to MKGAF’s over the last 12 months.

LBTSF's P/E Growth Rating (87) in the null industry is in the same range as MKGAF (92). This means that LBTSF’s stock grew similarly to MKGAF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LBTSFMKGAF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
Bullish Trend 3 days ago
68%
Momentum
ODDS (%)
N/A
Bearish Trend 3 days ago
66%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
13%
Bullish Trend 3 days ago
64%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
12%
Bullish Trend 3 days ago
62%
Advances
ODDS (%)
N/A
Bullish Trend 5 days ago
58%
Declines
ODDS (%)
N/A
Bearish Trend 10 days ago
63%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
MKGAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COSM0.650.01
+1.90%
Cosmos Health
CCEP88.881.46
+1.67%
Coca-Cola Europacific Partners plc
SSYS10.240.06
+0.59%
Stratasys Ltd
EPRX5.390.03
+0.56%
Eupraxia Pharmaceuticals
CORZ13.62N/A
N/A
Core Scientific

LBTSF and

Correlation & Price change

A.I.dvisor tells us that LBTSF and IPSEY have been poorly correlated (+16% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LBTSF and IPSEY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LBTSF
1D Price
Change %
LBTSF100%
N/A
IPSEY - LBTSF
16%
Poorly correlated
+3.39%
MEDXF - LBTSF
10%
Poorly correlated
N/A
LVRLF - LBTSF
3%
Poorly correlated
+1.96%
MKGAF - LBTSF
3%
Poorly correlated
+1.49%
KSPHF - LBTSF
0%
Poorly correlated
N/A
More

MKGAF and

Correlation & Price change

A.I.dvisor indicates that over the last year, MKGAF has been loosely correlated with MKKGY. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if MKGAF jumps, then MKKGY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MKGAF
1D Price
Change %
MKGAF100%
+1.49%
MKKGY - MKGAF
58%
Loosely correlated
+1.66%
PHCUF - MKGAF
20%
Poorly correlated
N/A
MEDXF - MKGAF
7%
Poorly correlated
N/A
OASMY - MKGAF
4%
Poorly correlated
N/A
LBTSF - MKGAF
3%
Poorly correlated
N/A
More